These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38957395)

  • 21. Corrigendum: Palmitoylethanolamide attenuates neurodevelopmental delay and early hippocampal damage following perinatal asphyxia in rats.
    Herrera MI; Udovin LD; Kobiec T; Toro-Urrego N; Kusnier CF; Kölliker-Frers RA; Luaces JP; Otero-Losada M; Capani F
    Front Behav Neurosci; 2022; 16():1115398. PubMed ID: 36600990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultra-micronized Palmitoylethanolamide Effects on Sleep-wake Rhythm and Neuropathic Pain Phenotypes in Patients with Carpal Tunnel Syndrome: An Open-label, Randomized Controlled Study.
    Evangelista M; Cilli ; De Vitis R; Militerno A; Fanfani F
    CNS Neurol Disord Drug Targets; 2018; 17(4):291-298. PubMed ID: 29676237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corrigendum: TAZ induces migration of microglia and promotes neurological recovery after spinal cord injury.
    Hu X; Huang J; Li Y; Dong L; Chen Y; Ouyang F; Li J; Li Z; Jing J; Cheng L
    Front Pharmacol; 2022; 13():995767. PubMed ID: 36160380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erratum to: A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury.
    Paterniti I; Impellizzeri D; Di Paola R; Navarra M; Cuzzocrea S; Esposito E
    J Neuroinflammation; 2016 May; 13(1):128. PubMed ID: 27245745
    [No Abstract]   [Full Text] [Related]  

  • 25. Corrigendum: An Inflammation-Centric View of Neurological Disease: Beyond the Neuron.
    Skaper SD; Facci L; Zusso M; Giusti P
    Front Cell Neurosci; 2019; 13():578. PubMed ID: 32116551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultramicronized palmitoylethanolamide treatment in central neuropathic pain following longstanding spinal cord injury: try to extinguish the fire after everything was burned.
    Polati E; Martini A; Schweiger V
    Pain; 2017 Apr; 158(4):763-764. PubMed ID: 28301405
    [No Abstract]   [Full Text] [Related]  

  • 27. Ultramicronized Palmitoylethanolamide (um-PEA) as Add-on Treatment in Fibromyalgia Syndrome (FMS): Retrospective Observational Study on 407 Patients.
    Schweiger V; Martini A; Bellamoli P; Donadello K; Schievano C; Balzo GD; Sarzi-Puttini P; Parolini M; Polati E
    CNS Neurol Disord Drug Targets; 2019; 18(4):326-333. PubMed ID: 30827269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyotrophic lateral sclerosis treatment with ultramicronized palmitoylethanolamide: a case report.
    Clemente S
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):933-6. PubMed ID: 22998138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corrigendum: Adenosine receptor stimulation by polydeoxyribonucleotide improves tissue repair and symptomology in experimental colitis.
    Pallio G; Bitto A; Pizzino G; Galfo F; Irrera N; Squadrito F; Squadrito G; Pallio S; Anastasi GP; Cutroneo G; Macrì A; Altavilla D
    Front Pharmacol; 2022; 13():1073445. PubMed ID: 36438841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonsurgical lumbar radiculopathies treated with ultramicronized palmitoylethanolamide (umPEA): A series of 100 cases.
    Chirchiglia D; Chirchiglia P; Signorelli F
    Neurol Neurochir Pol; 2018; 52(1):44-47. PubMed ID: 29157725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic paracetamol-induced analgesic and antihyperalgesic effects through activation of descending serotonergic pathways involving spinal 5-HT₇ receptors.
    Dogrul A; Seyrek M; Akgul EO; Cayci T; Kahraman S; Bolay H
    Eur J Pharmacol; 2012 Feb; 677(1-3):93-101. PubMed ID: 22206817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corrigendum: Triglyceride-mimetic prodrugs of buprenorphine enhance oral bioavailability via promotion of lymphatic transport.
    Quach T; Hu L; Han S; Lim SF; Senyschyn D; Yadav P; Trevaskis NL; Simpson JS; Porter CJH
    Front Pharmacol; 2022; 13():1014363. PubMed ID: 36133812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corrigendum: BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis.
    Herrmann FE; Hesslinger C; Wollin L; Nickolaus P
    Front Pharmacol; 2023; 14():1219760. PubMed ID: 37324497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corrigendum: Efficacy and Safety of Shenqu Xiaoshi Oral Liquid Compared With Domperidone Syrup in Children With Functional Dyspepsia.
    Yu Y; Xie XL; Wu J; Li ZY; He ZG; Liang CJ; Jin ZQ; Wang AZ; Gu J; Huang Y; Mei H; Shi W; Hu SY; Jiang X; Du J; Hu CJ; Gu L; Jiang ML; Mao ZQ; Xu CD
    Front Pharmacol; 2022; 13():920925. PubMed ID: 35770095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients.
    Noce A; Albanese M; Marrone G; Di Lauro M; Pietroboni Zaitseva A; Palazzetti D; Guerriero C; Paolino A; Pizzenti G; Di Daniele F; Romani A; D'Agostini C; Magrini A; Mercuri NB; Di Daniele N
    Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33917573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultramicronized Palmitoylethanolamide in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation.
    D'Amico R; Monaco F; Siracusa R; Cordaro M; Fusco R; Peritore AF; Gugliandolo E; Crupi R; Cuzzocrea S; Di Paola R; Impellizzeri D; Genovese T
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corrigendum: Dauricine attenuates vascular endothelial inflammation through inhibiting NF-κB pathway.
    Hu J; Chen R; An J; Wang Y; Liang M; Huang K
    Front Pharmacol; 2023; 14():1236892. PubMed ID: 37663242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corrigendum: Anakinra Therapy for Non-cancer Inflammatory Diseases.
    Cavalli G; Dinarello CA
    Front Pharmacol; 2019; 10():148. PubMed ID: 30906259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corrigendum: Could peripheral 5-HT level be used as a biomarker for depression diagnosis and treatment? A narrative minireview.
    Li C; Cai Q; Su Z; Chen Z; Cao J; Xu F
    Front Pharmacol; 2023; 14():1318433. PubMed ID: 38026939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corrigendum: Metformin Ameliorates Inflammation and Airway Remodeling of Experimental Allergic Asthma in Mice by Restoring AMPKα Activity.
    Ma W; Jin Q; Guo H; Han X; Xu L; Lu S; Wu C
    Front Pharmacol; 2022; 13():900127. PubMed ID: 35529435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.